With a market cap of has a large market cap size. Sanofi (NYSE: SNY) has been on the stock market since its IPO date on the 7/1/2002. Sanofi is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for Sanofi, is 2351.5, and so far today it has a volume of 0. Performance year to date since the 7/1/2002 is 2.69%.
To help you determine whether Sanofi is undervalued the following values will help you decide. P/E is 22.5 and forward P/E is 13.28. PEG perhaps more useful shows that Sanofi has a value for PEG of 3.17. P/S ratio is 2.85 and the P/B ratio is 1.7. The P/Cash and P/Free cash flow is *TBA and *TBA respectively.
At the current price Sanofi is trading at, 42.03 (0.00% today), Sanofi has a dividend yield of 3.88%, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is 1.87, and this is looking to grow in the next year to 0.16% after growing 4.10% this past year. EPS growth quarter over quarter is 4.60%, and -3.60% for sales growth quarter over quarter.
The number of shares outstanding is 2588.99, and the number of shares float is 2304.11. The senior management bring insider ownership to 16.40%, and institutional ownership is at 9.70%. The float short is 0.12%, with the short ratio at a value of 1.15. Management has seen a return on assets of *TBA, and also a return on investment of 6.50%.
The ability for Sanofi, to deal with debt, means it current ratio is *TBA, and quick ratio is *TBA. Long term debt/equity is *TBA and total debt/equity is *TBA. In terms of margins, Sanofi has a gross margin of 68.80%, with its operating margin at *TBA, and Sanofi has a profit margin of *TBA.
The 52 week high is -20.34%, with 16.39% being its 52 week low. The 20 day simple moving average is 4.62% and the 200 day simple moving average is 2.17%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.